Related Experiment Videos
Macrofollicular variant of papillary thyroid carcinoma
T Nakamura1, S Moriyama, S Nariya
1Department of Pathology, Suwa Red Cross Hospital, Japan.
Pathology International
|August 14, 1998
Summary
A rare macrofollicular variant of papillary thyroid carcinoma was found in an 18-year-old male. This well-differentiated tumor requires careful distinction from benign thyroid conditions.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
- Follicular variants of PTC can present diagnostic challenges.
- Macrofollicular patterns are typically associated with benign thyroid lesions.
Observation:
- A rare case of a macrofollicular variant of papillary thyroid carcinoma in an 18-year-old male is presented.
- The tumor exhibited a predominantly macrofollicular structure, mimicking adenomatous goiter or adenoma.
- Microfollicular or papillary foci with characteristic PTC nuclei were identified within the tumor.
- Incomplete capsular invasion and minimal vascular invasion were noted.
- Metastatic nodules were found in the residual thyroid lobe and lymph nodes.
Findings:
- Histopathological analysis revealed a predominantly macrofollicular structure with areas showing transition to microfollicular/papillary patterns.
- Characteristic nuclear features of papillary carcinoma were present in both macrofollicular and microfollicular areas.
- Immunohistochemistry indicated a small population of p53-positive tumor cells in the microfollicular/papillary regions.
- The presence of capsular and vascular invasion suggests potential for metastasis.
Implications:
- This case highlights the importance of recognizing the macrofollicular variant of papillary thyroid carcinoma.
- Distinguishing this variant from benign follicular lesions is crucial for appropriate patient management.
- The findings underscore the need for thorough histopathological evaluation, including immunohistochemistry, in suspected thyroid neoplasms.
- Early detection and accurate diagnosis are vital for managing potential metastatic disease.